Epigenetic Modifications in Lymphoma and Their Role in the Classification of Lymphomas
Details
Publication Year 2022,Volume 3,Issue #1,Page 174-187
Journal Title
Hemato
Publication Type
Review
Abstract
The characterisation of the lymphoma epigenome has provided insight into mechanisms involved in lymphomagenesis. Multiple lymphoma subtypes demonstrate recurrent mutations in key epigenetic regulators that have been utilised to define clinicogenetic groups that can predict clinical behaviour in these heterogenous entities. The high frequency of mutations in epigenetic regulators provides rationale to incorporate these in the classification of some subtypes of lymphoma. In addition, their recurrent nature provides a rationale to target such mutations, or the relevant pathway, for treatment. In this review, we summarised the available literature on epigenetic dysregulation in lymphoma and how it has been utilised in diagnosis and classification.
Keywords
lymphomagenesis; methylation; histone modification
Department(s)
Haematology
Open Access at Publisher's Site
https://doi.org/10.3390/hemato3010015
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-11-01 04:30:27
Last Modified: 2024-11-01 04:31:35

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙